HMGCS1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA036913

Antibody HPA036914

Antibody CAB032907

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Hepatocellular carcinomas and colorectal cancers along with several squamous cell carcinomas, urothelial, pancreatic, breast and gastric cancers showed moderate to strong cytoplasmic staining with additional nuclear and/or membranous immunoreactivity in a few cases. Remaining cancers were weakly stained or negative.Most of the malignant cells displayed moderate to strong cytoplasmic and nuclear immunoreactivity. Malignant gliomas and melanomas as well as thyroid and renal cancers along with several cases of malignant lymphomas were negative.A majority of malignancies showed weak to moderate cytoplasmic positivity. A few hepatocellular carcinomas were strongly stained. Malignant gliomas, lymphomas, melanomas and skin cancers were generally negative.

Validation

Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding partly similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected